ACAD
ACADIA Pharmaceuticals Inc
22.20$
-12.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -65.9% | -14.0% | +152.9% | -36.2% | -49.7% | +214.7% | +16.2% | -165.6% | – | +296.6% | – | |
| – | -5.0% | +237.7% | -53.5% | 0.0% | +102.9% | -43.4% | -139.3% | – | -0.9% | +2.4% | +105.5% | – | |
| – | -2.8% | -18.2% | +6.3% | +66.8% | -60.1% | +8.9% | +26.0% | -8.1% | +0.4% | +11.1% | +115.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -127.5% | – | – | +574.4% | -135.9% | – | -158.1% | – | – | +198.9% | – | |
| – | -100.0% | – | – | – | +547.1% | +21,718.5% | -0.3% | -99.6% | +932.2% | +30.1% | +97.6% | – | |
| – | -101.0% | +3,945.8% | +300.3% | +46.7% | – | -201.6% | -65.1% | +83.3% | -29.6% | – | -12.9% | – | |
| – | – | – | – | -200.0% | – | – | – | – | – | – | – | – | |
| – | -57.4% | -80.8% | +241.8% | -92.5% | +634.7% | -6.7% | +768.1% | -40.9% | +140.5% | -81.3% | +248.0% | – | |
| – | – | -82.2% | -271.6% | – | – | -162.0% | – | -88.1% | -1,942.2% | – | +98.3% | – | |
| – | – | -65.9% | -14.0% | +152.6% | -36.8% | -296.6% | – | -54.5% | -171.4% | – | +332.6% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.